TPS calculations of PD-L1 expression in NSCLC indicated a high consistency between the AI system and the pathologists (R = 0.9787) based on the Ventana PD-L1 (SP263) assay (141). This evidence concerns the gene CD274 and non-small cell lung carcinoma.